The NEC study covers research into rare and difficult to treat metastatic or advanced neuroendocrine carcinoma (NECs) of the gastrointestinal system. The study is searching for new treatment methods that can be developed by the mapping of neuroendocrine carcinomas, on the basis of DNA/RNA analysis. Ammodo supports the research as a means of contributing to the realisation of this DNA/RNA analysis in order to improve the treatment methods for NECs.

NEC study, 2016, Department of Moleculair Oncology, Voest group, Krijn Dijkstra & Sovann Kaing